Germano Geno J's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Aug 7, 2026
- Accession no.
- 0001178913-26-003949
- Filed
- Aug 7, 2026, 4:18 PM ET
- Trade date
- Aug 7, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Germano Geno JCIK 0001424383 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +25,014 | $0.00 | $0 | 65,014 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +50,000 | $0.00 | $0 | 50,000 | Direct | |
| Aug 7, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +43,014 | $0.00 | $0 | 43,014 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.